BREAKTHROUGH? China puts new leukemia drug to clinical tests
Chinese researchers have submitted a new leukemia drug for clinical trials, according to the Chinese Academy of Sciences. The new drug — HYML-122 — was approved by China National Drug Administration for clinical trials in June. The researchers, based in Anhui Province, spent four years developing the new drug, a source from the academy said. […]
Continue Reading